BACKGROUND: : Infection with Vibrio cholerae induces protection from subsequent severe disease, suggesting that an effective vaccine could be an important preventive strategy. Available vaccines provide less protection against cholera than natural infection, particularly in children. METHODS: : We examined a cohort of 121 children (2 years-12 years of age) and 276 older patients (>12 years of age) hospitalized with cholera in Dhaka, Bangladesh over a 4-year period, to compare clinical features in older patients and children and immune responses to key antigens. RESULTS: : Older patients had more severe disease. Children with cholera were more commonly retinol deficient, while zinc deficiency was equally prevalent in both groups. Children developed higher vibriocidal and serum immune responses to the B subunit of cholera toxin (CTB). In contrast, older patients mounted higher immune responses to 2 other key V. cholerae antigens, the lipopolysaccharide (LPS) and toxin coregulated pilus antigens (TcpA). We compared immune responses following infection with those occurring after receipt of a live, oral vaccine in both children and older patients in Bangladesh, during a similar time period. The response rates for vibriocidal and LPS antibodies were higher after infection than after vaccination. Both vaccinated older patients and children responded poorly to CTB and TcpA. CONCLUSIONS: : Although children developed vigorous vibriocidal and CTB-specific responses following infection, they had lessened responses to LPS and TcpA compared with older patients, as well as lessened responses to vaccination. More studies need to be carried out to determine factors, including micronutrient interventions that can improve responses in children to both natural infection and vaccination.
BACKGROUND: : Infection with Vibrio cholerae induces protection from subsequent severe disease, suggesting that an effective vaccine could be an important preventive strategy. Available vaccines provide less protection against cholera than natural infection, particularly in children. METHODS: : We examined a cohort of 121 children (2 years-12 years of age) and 276 older patients (>12 years of age) hospitalized with cholera in Dhaka, Bangladesh over a 4-year period, to compare clinical features in older patients and children and immune responses to key antigens. RESULTS: : Older patients had more severe disease. Children with cholera were more commonly retinol deficient, while zinc deficiency was equally prevalent in both groups. Children developed higher vibriocidal and serum immune responses to the B subunit of cholera toxin (CTB). In contrast, older patients mounted higher immune responses to 2 other key V. cholerae antigens, the lipopolysaccharide (LPS) and toxin coregulated pilus antigens (TcpA). We compared immune responses following infection with those occurring after receipt of a live, oral vaccine in both children and older patients in Bangladesh, during a similar time period. The response rates for vibriocidal and LPS antibodies were higher after infection than after vaccination. Both vaccinated older patients and children responded poorly to CTB and TcpA. CONCLUSIONS: : Although children developed vigorous vibriocidal and CTB-specific responses following infection, they had lessened responses to LPS and TcpA compared with older patients, as well as lessened responses to vaccination. More studies need to be carried out to determine factors, including micronutrient interventions that can improve responses in children to both natural infection and vaccination.
Authors: M John Albert; Firdausi Qadri; Mohammad A Wahed; Tanvir Ahmed; A S M Hamidur Rahman; Firoz Ahmed; Nurul A Bhuiyan; K Zaman; Abdullah H Baqui; John D Clemens; Robert E Black Journal: J Infect Dis Date: 2003-03-06 Impact factor: 5.226
Authors: Marcelino E S Lucas; Jacqueline L Deen; Lorenz von Seidlein; Xuan-Yi Wang; Julia Ampuero; Mahesh Puri; Mohammad Ali; M Ansaruzzaman; Juvenaldo Amos; Arminda Macuamule; Philippe Cavailler; Philippe J Guerin; Claude Mahoudeau; Pierre Kahozi-Sangwa; Claire-Lise Chaignat; Avertino Barreto; Francisco F Songane; John D Clemens Journal: N Engl J Med Date: 2005-02-24 Impact factor: 91.245
Authors: Muhammad Asaduzzaman; Edward T Ryan; Manohar John; Long Hang; Ashraful I Khan; A S G Faruque; Ronald K Taylor; Stephen B Calderwood; Firdausi Qadri Journal: Infect Immun Date: 2004-08 Impact factor: 3.441
Authors: Firdausi Qadri; Tanvir Ahmed; Mohammad A Wahed; Firoz Ahmed; Nurul A Bhuiyan; A S M Hamidur Rahman; John D Clemens; Robert E Black; M John Albert Journal: Vaccine Date: 2004-01-02 Impact factor: 3.641
Authors: Firdausi Qadri; Edward T Ryan; A S G Faruque; Firoz Ahmed; Ashraful Islam Khan; M Monirul Islam; Syed M Akramuzzaman; David A Sack; Stephen B Calderwood Journal: Infect Immun Date: 2003-08 Impact factor: 3.441
Authors: Tom H Karlsen; Halvor Sommerfelt; Skjalg Klomstad; Per Kragh Andersen; Tor A Strand; Rune J Ulvik; Christina Ahrén; Harleen M S Grewal Journal: Infect Immun Date: 2003-07 Impact factor: 3.441
Authors: R Bradley Sack; A Kasem Siddique; Ira M Longini; Azhar Nizam; Md Yunus; M Sirajul Islam; J Glenn Morris; Afsar Ali; Anwar Huq; G Balakrish Nair; Firdausi Qadri; Shah M Faruque; David A Sack; Rita R Colwell Journal: J Infect Dis Date: 2002-12-13 Impact factor: 5.226
Authors: Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan Journal: Clin Vaccine Immunol Date: 2012-03-21
Authors: Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney Journal: Curr Environ Health Rep Date: 2016-09
Authors: Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri Journal: Clin Vaccine Immunol Date: 2011-02-23
Authors: Leslie M Mayo-Smith; Jakub K Simon; Wilbur H Chen; Douglas Haney; Michael Lock; Caroline E Lyon; Stephen B Calderwood; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Jason B Harris Journal: Clin Vaccine Immunol Date: 2017-01-05
Authors: Mindy S Lim; Dixon Ng; ZuSheng Zong; Andrew S Arvai; Ronald K Taylor; John A Tainer; Lisa Craig Journal: Mol Microbiol Date: 2010-06-01 Impact factor: 3.501
Authors: Taufiqur Rahman Bhuiyan; Samuel B Lundin; Ashraful Islam Khan; Anna Lundgren; Jason B Harris; Stephen B Calderwood; Firdausi Qadri Journal: Infect Immun Date: 2009-02-23 Impact factor: 3.441
Authors: Ashraful I Khan; Fahima Chowdhury; Jason B Harris; Regina C Larocque; Abu S G Faruque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri Journal: Scand J Infect Dis Date: 2010
Authors: Jason B Harris; Michael J Podolsky; Taufiqur R Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Tanya Logvinenko; Jennifer Kendall; Abu S G Faruque; Cathryn R Nagler; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood Journal: PLoS Negl Trop Dis Date: 2009-03-31